MAC-话题@MedSci

#MAC#

655篇内容 | 2621人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1996450, encodeId=3c88199645072, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Clin Pharmacol Ther:Secukinumab治疗银屑病的创新儿科开发之路, objectType=article, longId=294274, objectId=fe2d2942e48c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe2d2942e48c, replyNumber=0, likeNumber=106, createdTime=2023-01-02, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe2d2942e48c, moduleTitle=Clin Pharmacol Ther:Secukinumab治疗银屑病的创新儿科开发之路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe2d2942e48c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996457, encodeId=7ad3199645e0f, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Front Pharmacol：抗中性粒细胞胞浆抗体相关性血管炎的肠-肾轴：肠道微生物区系组成分析, objectType=article, longId=301327, objectId=af6b30132ef6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af6b30132ef6, replyNumber=0, likeNumber=88, createdTime=2022-07-21, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af6b30132ef6, moduleTitle=Front Pharmacol：抗中性粒细胞胞浆抗体相关性血管炎的肠-肾轴：肠道微生物区系组成分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af6b30132ef6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996478, encodeId=426319964e8c2, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Front Pharmacol：栀子豉汤通过调节GSH/GSSG途径减轻氧化应激损伤逆转CUMS大鼠抑郁行为, objectType=article, longId=728082, objectId=629ee28082cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=629ee28082cf, replyNumber=0, likeNumber=91, createdTime=2022-10-22, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=629ee28082cf, moduleTitle=Front Pharmacol：栀子豉汤通过调节GSH/GSSG途径减轻氧化应激损伤逆转CUMS大鼠抑郁行为, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=629ee28082cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996484, encodeId=984419964848d, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Front Pharmacol：紫草及其活性成分治疗银屑病的证据及作用机制, objectType=article, longId=728081, objectId=3b0ce28081d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b0ce28081d5, replyNumber=0, likeNumber=85, createdTime=2022-08-31, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b0ce28081d5, moduleTitle=Front Pharmacol：紫草及其活性成分治疗银屑病的证据及作用机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b0ce28081d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996436, encodeId=67d4199643694, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Rhizen Pharmaceuticals AG宣布在Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌的II期研究中首次向患者给药, objectType=article, longId=218658, objectId=c75f218658a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c75f218658a9, replyNumber=0, likeNumber=83, createdTime=2021-12-05, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c75f218658a9, moduleTitle=Rhizen Pharmaceuticals AG宣布在Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌的II期研究中首次向患者给药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c75f218658a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996443, encodeId=6fa6199644307, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Front Pharmacol：microRNA在肺栓塞中的作用, objectType=article, longId=219945, objectId=d7e2219945a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7e2219945a9, replyNumber=0, likeNumber=67, createdTime=2022-07-11, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7e2219945a9, moduleTitle=Front Pharmacol：microRNA在肺栓塞中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7e2219945a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996448, encodeId=bf3c1996448ae, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Liverpool CCG和Community Pharmacy Liverpool在100多家社区药房推出FebriDx®服务, objectType=article, longId=294033, objectId=9a9f29403370, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a9f29403370, replyNumber=0, likeNumber=61, createdTime=2022-03-31, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a9f29403370, moduleTitle=Liverpool CCG和Community Pharmacy Liverpool在100多家社区药房推出FebriDx®服务, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a9f29403370)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996451, encodeId=4e941996451b6, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Pharmacol Res：GIP和GLP-2共同改善支持GIPR-GLP-2R共激动剂作为未来骨质疏松症治疗的人类骨转换, objectType=article, longId=294731, objectId=07dc294e315d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07dc294e315d, replyNumber=0, likeNumber=67, createdTime=2022-02-21, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07dc294e315d, moduleTitle=Pharmacol Res：GIP和GLP-2共同改善支持GIPR-GLP-2R共激动剂作为未来骨质疏松症治疗的人类骨转换, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07dc294e315d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996432, encodeId=892b199643291, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Pharmacol Ther：睡眠呼吸暂停和肺动脉高压：一个有待解决的谜语, objectType=article, longId=218101, objectId=f8862181012d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8862181012d, replyNumber=0, likeNumber=96, createdTime=2022-06-08, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8862181012d, moduleTitle=Pharmacol Ther：睡眠呼吸暂停和肺动脉高压：一个有待解决的谜语, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8862181012d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996485, encodeId=c1d3199648538, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Inflammopharmacology：褪黑激素可作为非手术治疗牙周炎的辅助疗法, objectType=article, longId=729261, objectId=a1f2e2926139, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1f2e2926139, replyNumber=0, likeNumber=191, createdTime=2022-10-18, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1f2e2926139, moduleTitle=Inflammopharmacology：褪黑激素可作为非手术治疗牙周炎的辅助疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1f2e2926139)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996427, encodeId=4e2b199642e74, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Rhizen Pharmaceuticals AG宣布，RP7214治疗新冠肺炎患者2期研究进行首例患者给药, objectType=article, longId=217612, objectId=ab6b21e61271, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab6b21e61271, replyNumber=0, likeNumber=59, createdTime=2021-12-08, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab6b21e61271, moduleTitle=Rhizen Pharmaceuticals AG宣布，RP7214治疗新冠肺炎患者2期研究进行首例患者给药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab6b21e61271)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996468, encodeId=0c92199646844, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Neuropsychopharmacology：江西省精神卫生中心杨远坚团队发现长寿因子Klotho或具有抗抑郁潜能, objectType=article, longId=724977, objectId=5d00e2497702, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d00e2497702, replyNumber=0, likeNumber=92, createdTime=2022-10-13, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d00e2497702, moduleTitle=Neuropsychopharmacology：江西省精神卫生中心杨远坚团队发现长寿因子Klotho或具有抗抑郁潜能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d00e2497702)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996466, encodeId=e8031996466c1, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Pharmacol Res：四妙勇安汤(SMYAD)的主要活性成分通过PDE5A-AKT和TLR4-NOX4通路在异丙肾上腺素(ISO)诱导的心力衰竭模型中抑制自噬和凋亡, objectType=article, longId=724691, objectId=cf36e2469145, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf36e2469145, replyNumber=0, likeNumber=80, createdTime=2022-08-10, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf36e2469145, moduleTitle=Pharmacol Res：四妙勇安汤(SMYAD)的主要活性成分通过PDE5A-AKT和TLR4-NOX4通路在异丙肾上腺素(ISO)诱导的心力衰竭模型中抑制自噬和凋亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf36e2469145)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996422, encodeId=1b46199642258, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Biomed Pharmacother：中医药联合肺部给药系统防治特发性肺纤维化可行性探讨, objectType=article, longId=215787, objectId=0a39215e873e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a39215e873e, replyNumber=0, likeNumber=76, createdTime=2022-02-10, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a39215e873e, moduleTitle=Biomed Pharmacother：中医药联合肺部给药系统防治特发性肺纤维化可行性探讨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a39215e873e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996458, encodeId=6d391996458da, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Biomed Pharmacother：中药及天然提取物治疗狼疮性肾炎的进展, objectType=article, longId=301385, objectId=92e13013853f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92e13013853f, replyNumber=0, likeNumber=91, createdTime=2022-05-01, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92e13013853f, moduleTitle=Biomed Pharmacother：中药及天然提取物治疗狼疮性肾炎的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92e13013853f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996463, encodeId=6c92199646361, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Front Pharmacol：四妙勇安汤治疗糖尿病视网膜病变的网络药理学与体内结合研究, objectType=article, longId=724296, objectId=92f6e24296f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92f6e24296f3, replyNumber=0, likeNumber=80, createdTime=2022-10-12, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92f6e24296f3, moduleTitle=Front Pharmacol：四妙勇安汤治疗糖尿病视网膜病变的网络药理学与体内结合研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92f6e24296f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996487, encodeId=09ee199648ed5, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Front Pharmacol：中草药对特发性膜性肾病 (REACH-MN) 的影响, objectType=article, longId=729650, objectId=c924e2965071, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c924e2965071, replyNumber=0, likeNumber=89, createdTime=2023-04-29, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c924e2965071, moduleTitle=Front Pharmacol：中草药对特发性膜性肾病 (REACH-MN) 的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c924e2965071)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996454, encodeId=d01a1996454e1, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Eur Rev Med Pharmacol Sci：在意大利COVID-19大流行封锁期间，艾多沙班治疗狼疮抗凝物阳性患者静脉血栓栓塞/肺栓塞的真实世界研究, objectType=article, longId=299655, objectId=33a02996554c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33a02996554c, replyNumber=0, likeNumber=61, createdTime=2022-09-25, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33a02996554c, moduleTitle=Eur Rev Med Pharmacol Sci：在意大利COVID-19大流行封锁期间，艾多沙班治疗狼疮抗凝物阳性患者静脉血栓栓塞/肺栓塞的真实世界研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33a02996554c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996508, encodeId=c0fa1996508cd, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=胃癌（carcinoma of stomach）内镜-CT病例图片影像诊断分析, objectType=article, longId=287542, objectId=57a928e5421b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57a928e5421b, replyNumber=0, likeNumber=94, createdTime=2021-12-26, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57a928e5421b, moduleTitle=胃癌（carcinoma of stomach）内镜-CT病例图片影像诊断分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57a928e5421b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996434, encodeId=f5d81996434f8, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Clin Pharmacol Ther ：2型糖尿病患者中GLP-1 RA和DPP-4抑制剂的使用与肠梗阻风险增加相关, objectType=article, longId=218302, objectId=3ada21830258, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ada21830258, replyNumber=0, likeNumber=79, createdTime=2022-05-24, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ada21830258, moduleTitle=Clin Pharmacol Ther ：2型糖尿病患者中GLP-1 RA和DPP-4抑制剂的使用与肠梗阻风险增加相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ada21830258)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

MAC

2020-05-29

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Clin Pharmacol Ther:Secukinumab治疗银屑病的创新儿科开发之路

2023-01-02

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Front Pharmacol：抗中性粒细胞胞浆抗体相关性血管炎的肠-肾轴：肠道微生物区系组成分析

2022-07-21

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Front Pharmacol：栀子豉汤通过调节GSH/GSSG途径减轻氧化应激损伤逆转CUMS大鼠抑郁行为

2022-10-22

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Front Pharmacol：紫草及其活性成分治疗银屑病的证据及作用机制

2022-08-31

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Rhizen Pharmaceuticals AG宣布在Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌的II期研究中首次向患者给药

2021-12-05

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Front Pharmacol：microRNA在肺栓塞中的作用

2022-07-11

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Liverpool CCG和Community Pharmacy Liverpool在100多家社区药房推出FebriDx®服务

2022-03-31

医者仁心 (审核中...)

前往app查看评论内容

#MAC#

Pharmacol Res：GIP和GLP-2共同改善支持GIPR-GLP-2R共激动剂作为未来骨质疏松症治疗的人类骨转换

2022-02-21

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Pharmacol Ther：睡眠呼吸暂停和肺动脉高压：一个有待解决的谜语

2022-06-08

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Inflammopharmacology：褪黑激素可作为非手术治疗牙周炎的辅助疗法

2022-10-18

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Rhizen Pharmaceuticals AG宣布，RP7214治疗新冠肺炎患者2期研究进行首例患者给药

2021-12-08

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Neuropsychopharmacology：江西省精神卫生中心杨远坚团队发现长寿因子Klotho或具有抗抑郁潜能

2022-10-13

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Pharmacol Res：四妙勇安汤(SMYAD)的主要活性成分通过PDE5A-AKT和TLR4-NOX4通路在异丙肾上腺素(ISO)诱导的心力衰竭模型中抑制自噬和凋亡

2022-08-10

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Biomed Pharmacother：中医药联合肺部给药系统防治特发性肺纤维化可行性探讨

2022-02-10

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Biomed Pharmacother：中药及天然提取物治疗狼疮性肾炎的进展

2022-05-01

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Front Pharmacol：四妙勇安汤治疗糖尿病视网膜病变的网络药理学与体内结合研究

2022-10-12

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Front Pharmacol：中草药对特发性膜性肾病 (REACH-MN) 的影响

2023-04-29

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Eur Rev Med Pharmacol Sci：在意大利COVID-19大流行封锁期间，艾多沙班治疗狼疮抗凝物阳性患者静脉血栓栓塞/肺栓塞的真实世界研究

2022-09-25

yb6560 (审核中...)

前往app查看评论内容

#MAC#

胃癌（carcinoma of stomach）内镜-CT病例图片影像诊断分析

2021-12-26

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Clin Pharmacol Ther ：2型糖尿病患者中GLP-1 RA和DPP-4抑制剂的使用与肠梗阻风险增加相关

2022-05-24

科室
- - 订阅+
  - 更多科室
工具
服务